awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48369496-38EC119A-A2F6-4F44-97EF-6AC750B08B32
Q48369496-38EC119A-A2F6-4F44-97EF-6AC750B08B32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48369496-38EC119A-A2F6-4F44-97EF-6AC750B08B32
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
P2860
Q48369496-38EC119A-A2F6-4F44-97EF-6AC750B08B32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48369496-38EC119A-A2F6-4F44-97EF-6AC750B08B32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d535953e25114bfa89b34c9fc4362050d30135e1
P2860
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.